Client improves medication adherence rate by up to 20%
BOSTON, Mass.—July 24, 2017—Health Dialog, a leading provider of integrated population health management solutions for health plans, risk-bearing providers and self-insured employers, introduced today comprehensive Medication Therapy Management (MTM) services for health plans. The new MTM services combine powerful analytics with skilled health coaching to help patients overcome barriers to proper medication use, identify medication-related problems, promote coordination of care and improve medication management success.
“The barriers to medication adherence are unique to each person,” said Karen Staniforth, Health Dialog’s chief operating officer. “Our analytics leverage two decades of data and more than 1,500 data points per person to identify highly personalized interventions that address each person’s unique circumstances, attitudes, challenges and preferences. Combined with highly skilled health coaches, our formula is proven to positively impact patient outcomes, which can have a measureable impact on a health plan’s bottom line.”
Poor medication adherence is a pervasive problem that costs the healthcare system as much as $290 billion a year. It negatively impacts patient outcomes, leading to more hospitalizations and higher long-term costs. In an eight-month study with its first MTM client, Health Dialog found that members who participated in one telephone coaching session vs. those who did not achieved the following:
- 20% higher rate of adherence for members on hypertension medication.
- 15% higher rate of adherence for members on diabetes medication.
- 15% higher rate of individuals with diabetes filling at least one statin medication.
In addition to helping health plans significantly reduce the substantial cost of poor medication adherence, the new MTM services can also improve HEDIS scores and several Five-Star Quality Ratings associated with medication use and safety. HEDIS and Star Rating adherence measures have become increasingly competitive. Over the past five years, the Five-Star adherence measure cut points have increased between three and seven percentage points for Medicare Advantage Prescription Drug (MA-PD) plans and between four and eight points for Prescription Drug Plans (PDPs).
To help meet these challenges, Health Dialog’s MTM services use proprietary analytics to identify individuals who are both non-compliant to drug therapy guidelines or eligible for comprehensive medication reviews (CMRs) (based on CMS and health plan parameters). Significantly, Health Dialog analytics also prioritize those likely to be receptive to intervention. Once identified, the Health Dialog MTM team assesses these individuals’ medication history and identifies issues that need immediate attention. Registered nurse health coaches, pharmacists and medication specialists trained in chronic disease management, patient education and behavior change methodologies engage with individuals to recognize and resolve medication-related issues and help individuals overcome barriers.
To learn more about Health Dialog’s MTM services, please visit https://insights.healthdialog.com/white-papers/medication-adherence for a white paper highlighting a successful case study.
About Health Dialog:
Health Dialog is a leading provider of population health management solutions. The company works with the nation’s largest third-party payers, employers and providers to improve the health and wellness of their members, employees and patients while reducing costs and improving performance in key quality measures, such as NCQA’s HEDIS and CMS’ Stars ratings. Health Dialog’s unique capabilities include analytics, a patient portal, a multi-channel coaching platform, shared decision-making tools and a 24/7 nurse line. For more information, visit www.healthdialog.com. Health Dialog is a wholly owned subsidiary of Rite Aid Corporation (NYSE:RAD).
*20% higher rate for proportion of days covered.
*15% higher rate for proportion of days covered.